Skip to main content

Table 1 Inclusion and exclusion criteria for study participation in the NILS feasibility study

From: A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise

Inclusion criteria

Exclusion criteria

Biopsy-proven prostate cancer within 2 years prior to enrolment

Less than 10 years of life expectancy

PSA ≤ 10, Gleason score ≤ 6, clinical classification ≤ cT2a or PSA ≤ 10, Gleason score ≤ 7, clinical classification ≤ cT2a

Prior history of cancer, except for non-melanoma skin cancer, unless considered cured without signs of treatment failure for at least 5 years

Maximum 1/5 tumour-positive biopsy rate

Conditions or behaviours likely to affect the capability of participating fully in the intervention

On active surveillance (elected to forgo treatment)

Moderate to severe co-morbidity (kidney, liver, heart, or respiratory problems)

Level of testosterone normal in sera

Inflammatory bowel disease or physical handicaps

Above 55 and below 70 years of agea

Gluten intolerance

  1. aWas adjusted to include the age span of 53–72 years